Prakash Sawaldas Khetani
About Prakash Sawaldas Khetani
Data last updated:
Prakash Sawaldas Khetani is a Designated Partner at Britly Pharma Llp (since 2022) and Director at Medi-Vesp Pharma Private Limited (since 2013). The companies operate in Paper and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹27.1 Lakh; the largest is Britly Pharma Llp at ₹19.6 Lakh (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Britly Pharma Llp ABZ-0902 | Designated Partner | 16 Nov 2022 | 2022 | ₹19.6 Lakh (FY 2026) | Active |
| Medi-Vesp Pharma Private Limited U36100MH2013PTC250045 | Director | 13 Nov 2013 | 2013 | ₹7.5 Lakh (FY 2023) | Active |
Board colleagues of Prakash Sawaldas Khetani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sirajuddin Noorul Huda | 06680640 | Britly Pharma Llp , Medi-Vesp Pharma Private Limited | Designated Partner |
| Vahidullah Najibullah Khan | 06680657 | Britly Pharma Llp , Medi-Vesp Pharma Private Limited | Designated Partner |
| Ehtesham Mohd Faiz Ahmed Shaikh | 06680616 | Medi-Vesp Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prakash Sawaldas Khetani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prakash Sawaldas Khetani
Prakash Sawaldas Khetani currently holds 2 directorships: Britly Pharma Llp (Designated Partner, since 16 Nov 2022, revenue ₹19.6 Lakh (FY 2026)); Medi-Vesp Pharma Private Limited (Director, since 13 Nov 2013, revenue ₹7.5 Lakh (FY 2023)).
Prakash Sawaldas Khetani was first appointed on 13 Nov 2013 as Director at Medi-Vesp Pharma Private Limited. The most recent appointment on record is 16 Nov 2022 at Britly Pharma Llp.
The 2 current companies of Prakash Sawaldas Khetani that report revenue have a combined latest revenue of ₹27.1 Lakh: Britly Pharma Llp ₹19.6 Lakh (FY 2026); Medi-Vesp Pharma Private Limited ₹7.5 Lakh (FY 2023).
The current boards of Prakash Sawaldas Khetani's companies include Sirajuddin Noorul Huda (Britly Pharma Llp), Vahidullah Najibullah Khan (Britly Pharma Llp), Ehtesham Mohd Faiz Ahmed Shaikh (Medi-Vesp Pharma Private Limited).